Annals of Clinical and Translational Neurology (Jul 2019)

Second‐hit DEPDC5 mutation is limited to dysmorphic neurons in cortical dysplasia type IIA

  • Wei Shern Lee,
  • Sarah E. M. Stephenson,
  • Katherine B. Howell,
  • Kate Pope,
  • Greta Gillies,
  • Alison Wray,
  • Wirginia Maixner,
  • Simone A. Mandelstam,
  • Samuel F. Berkovic,
  • Ingrid E. Scheffer,
  • Duncan MacGregor,
  • Anthony Simon Harvey,
  • Paul J. Lockhart,
  • Richard J. Leventer

DOI
https://doi.org/10.1002/acn3.50815
Journal volume & issue
Vol. 6, no. 7
pp. 1338 – 1344

Abstract

Read online

Abstract Focal cortical dysplasia (FCD) causes drug‐resistant epilepsy and is associated with pathogenic variants in mTOR pathway genes. How germline variants cause these focal lesions is unclear, however a germline + somatic “2‐hit” model is hypothesized. In a boy with drug‐resistant epilepsy, FCD, and a germline DEPDC5 pathogenic variant, we show that a second‐hit DEPDC5 variant is limited to dysmorphic neurons, and the somatic mutation load correlates with both dysmorphic neuron density and the epileptogenic zone. These findings provide new insights into the molecular and cellular correlates of FCD determining drug‐resistant epilepsy and refine conceptualization of the epileptogenic zone.